Slideshow

New FDA Warning

Author(s):

James Phelps, MD

A rare but serious reaction to this treatment can have immunological consequences. As with all medications, however, the latest alert does not change how psychiatrists manage the risks.

Related Videos
journey
Related Content
bipolar
January 19th 2025

Addressing Comorbid Bipolar Disorder and ADHD

Mark Jankelow, MSN, PMHNP-BC
Blue Light, Depression, and Bipolar Disorder
August 4th 2021

Blue Light, Depression, and Bipolar Disorder

Chris Aiken, MD Kellie Newsome, PMH-NP
bipolar
January 17th 2025

The Most Common Challenges in Treating Bipolar Disorder

Mark Jankelow, MSN, PMHNP-BC
Four Myths About Lamotrigine
August 3rd 2021

Four Myths About Lamotrigine

Chris Aiken, MD Kellie Newsome, PMH-NP
renal
December 20th 2024

Demystifying Lithium Therapy—A Primer for Clinicians: Renal Issues, Part 1

Jonathan M. Meyer, MD, DLFAPA
Gift Guide for Psychiatric Readers
November 29th 2024

Gift Guide for Psychiatric Readers

Megan McSweeney
© 2025 MJH Life Sciences

All rights reserved.